| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| CABAZITAXEL SANDOZ 10 mg/ml | CABAZITAXELUM | CONC. PT. SOL. PERF. | L01CD04 | W70420002 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| CABAZITAXEL SANDOZ 10 mg/ml | CABAZITAXELUM | CONC. PT. SOL. PERF. | L01CD04 | W70420003 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| CABAZITAXEL SANDOZ 10 mg/ml | CABAZITAXELUM | CONC. PT. SOL. PERF. | L01CD04 | W70420004 | SANDOZ PHARMACEUTICALS S.R.L. - ROMANIA | ||||||
| CABAZITAXEL STADA 20 mg/ml | CABAZITAXELUM | CONC. PT. SOL. PERF. | L01CD04 | W69378001 | STADA M&D SRL - ROMANIA | ||||||
| CABLIVI 10 mg | CAPLACIZUMABUM | PULB.+SOLV. PT. SOL. INJ. | B01AX07 | W65588001 | ABLYNX NV - BELGIA | X | |||||
| CABLIVI 10 mg | CAPLACIZUMABUM | PULB.+SOLV. PT. SOL. INJ. | B01AX07 | W65588002 | ABLYNX NV - BELGIA | X | |||||
| CABLIVI 10 mg | CAPLACIZUMABUM | PULB.+SOLV. PT. SOL. INJ. | B01AX07 | W65588003 | ABLYNX NV - BELGIA | X | |||||
| CABOMETYX 20 mg | CABOZANTINIBUM | COMPR. FILM. | L01EX07 | W64527001 | IPSEN PHARMA - FRANTA | X | |||||
| CABOMETYX 40 mg | CABOZANTINIBUM | COMPR. FILM. | L01EX07 | W64528001 | IPSEN PHARMA - FRANTA | X | |||||
| CABOMETYX 60 mg | CABOZANTINIBUM | COMPR. FILM. | L01EX07 | W64529001 | IPSEN PHARMA - FRANTA | X | |||||
| CADUET 10mg/10mg | COMBINATII (ATORVASTATINUM+AMLODIPINUM) | COMPR. FILM. | C10BX03 | W67263001 | UPJOHN EESV - OLANDA | ||||||
| CADUET 10mg/5mg | COMBINATII (ATORVASTATINUM+AMLODIPINUM) | COMPR. FILM. | C10BX03 | W67262001 | UPJOHN EESV - OLANDA | ||||||
| CAELYX PEGYLATED LIPOSOMAL 2 mg/ml | DOXORUBICINUM | CONC. PT. SOL. PERF. | L01DB01 | W67977001 | BAXTER HOLDING B.V. - OLANDA | X | |||||
| CAELYX PEGYLATED LIPOSOMAL 2 mg/ml | DOXORUBICINUM | CONC. PT. SOL. PERF. | L01DB01 | W67977002 | BAXTER HOLDING B.V. - OLANDA | X | |||||
| CAELYX PEGYLATED LIPOSOMAL 2 mg/ml | DOXORUBICINUM | CONC. PT. SOL. PERF. | L01DB01 | W67977003 | BAXTER HOLDING B.V. - OLANDA | X | |||||
| CAELYX PEGYLATED LIPOSOMAL 2 mg/ml | DOXORUBICINUM | CONC. PT. SOL. PERF. | L01DB01 | W67977004 | BAXTER HOLDING B.V. - OLANDA | X | |||||
| CAFFETIN | COMBINATII (PARACETAMOLUM+PROPYPHENAZONUM+CAFEINUM+CODEINUM) | COMPR. | N02BE51 | W59787001 | ALKALOID-INT D.O.O. - SLOVENIA | ||||||
| CAFFETIN | COMBINATII (PARACETAMOLUM+PROPYPHENAZONUM+CAFEINUM+CODEINUM) | COMPR. | N02BE51 | W59787002 | ALKALOID-INT D.O.O. - SLOVENIA | ||||||
| CAFFETIN COLD PLUS | COMBINATII (PARACETAMOLUM+ACIDUM ASCORBICUM+PSEUDOEPHEDRINUM+DEXTROMETHORPHANUM) | COMPR. FILM. | N02BE51 | W66875001 | INN-FARM D.O.O. - SLOVENIA | ||||||
| CAFFETIN COLDMAX 1000 mg/12,2 mg | COMBINATII (PARACETAMOLUM+PHENYLEPHRINUM) | PULB. PT. SOL. ORALA IN PLIC | N02BE51 | W58337001 | ALKALOID-INT D.O.O. - SLOVENIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman